Covid vaccine clinical study underway in BOP The clinical study is underway in Rotorua and Christchurch. Photo: MOH. '); } else { // } A clinical study getting underway in Rotorua and Christchurch is expected to provide valuable information on how New Zealand’s unique population responds to the Pfizer-BioNTech Covid-19 vaccine. The study, ‘Ka Mātau, Ka Ora' (from knowledge comes wellbeing), is being led by Vaccine Alliance Aotearoa New Zealand – Ohu Kaupare Huaketo and is being undertaken to inform the national Covid-19 strategy and ultimately enhance vaccine effectiveness and confidence. “While the Pfizer-BioNTech vaccine has demonstrated efficacy and safety in pivotal clinical trials and real-world studies, it has not yet been studied in New Zealand,” says the Malaghan Institute’s Dr Fran Priddy, VAANZ Clinical Director.